Investor Relations Home

Accuray Incorporated is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.

Accuray does not assume a duty to update information on this website, except through the normal quarterly financial press releases and regulatory filings.

Investor Presentation

Download Documentation February 2018 RBC Capital Markets Global Healthcare Conference Investor Presentation
ARAY (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$5.05
Change (%) Stock is Down 0.1 (1.94%)
Volume512,490
Data as of Feb 22, 2018 4:00 p.m. ET
Refresh quote
Stock chart for: ARAY.O.  Currently trading at $5.05 with a 52 week high of $6.15 and a 52 week low of $3.60.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Press Releases

Accuray to Present at the 2018 RBC Capital Markets Global Healthcare Conference on February 22, 2018
SUNNYVALE, Calif., Feb. 15, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will present at the 2018 RBC Capital Markets Global Healthcare Conference at the Lotte New York Palace Hotel in New York on Thursday... 
Feb 15, 2018
Accuray Retires February 2018 Convertible Notes
-- Company Continues to Execute Strategies to Reduce Total Debt While Minimizing Shareholder Dilution -- SUNNYVALE, Calif., Feb. 5, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has retired all February 2018 convert... 
Feb 5, 2018

Upcoming Investor Event

There are currently no events scheduled.
Some documents in the Investor Relations section require that you have Adobe Acrobat Reader® installed in order to view files in PDF format. Download the newest version of Acrobat Reader